pharmaceutical market research provides up-to-date listings of new and current pharma market research with sample pages and Tables of Contents to help make the right choices when buying off-the-shelf market research reports.

Free Research Report Download:
The Cancer Market Outlook To 2014: Competitive landscape, market size, pipeline analysis and growth opportunities
The Cancer Market Outlook To 2014



Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy

Market Research Reports By Category

Indication Areas

Previous 5 6 7 8 9 10 11 12 13 14 Next

Afinitor - A Two-Pronged Attack Against Tuberous Sclerosis Complex
Published by GlobalData in May 2012
Afinitor - A Two-Pronged Attack Against Tuberous Sclerosis ComplexSummaryGlobalData?s new alert, "Afinitor - A Two-Pronged Attack Against Tuberous Sclerosis Complex?, takes a look at the implications of the FDA?s recent approval of the drug for the treatment of ang...(more)

Orthostatic Hypotension Global Clinical Trials Review, H1, 2012
Published by GlobalData in May 2012
Orthostatic Hypotension Global Clinical Trials Review, H1, 2012SummaryGlobalData's clinical trial report, ?Orthostatic Hypotension Global Clinical Trials Review, H1, 2012" provides data on the Orthostatic Hypotension clinical trial scenario. This report provides el...(more)

Carcinomas Global Clinical Trials Review, H1, 2012
Published by GlobalData in May 2012
Carcinomas Global Clinical Trials Review, H1, 2012SummaryGlobalData's clinical trial report, ?Carcinomas Global Clinical Trials Review, H1, 2012" provides data on the Carcinomas clinical trial scenario. This report provides elemental information and data relating t...(more)

Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012
Published by GlobalData in May 2012
Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012SummaryGlobalData's clinical trial report, ?Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides...(more)

Precancerous Condition Global Clinical Trials Review, H1, 2012
Published by GlobalData in May 2012
Precancerous Condition Global Clinical Trials Review, H1, 2012SummaryGlobalData's clinical trial report, ?Precancerous Condition Global Clinical Trials Review, H1, 2012" provides data on the Precancerous Condition clinical trial scenario. This report provides eleme...(more)

Metastatic Cancer Global Clinical Trials Review, H1, 2012
Published by GlobalData in May 2012
Metastatic Cancer Global Clinical Trials Review, H1, 2012SummaryGlobalData's clinical trial report, ?Metastatic Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Cancer clinical trial scenario. This report provides elemental informatio...(more)

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
Published by GBI Research in May 2012
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic SubstitutionSummaryGBI Research, the leading business intelligence provider, has released its latest research ?Generics ...(more)

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Published by GBI Research in May 2012
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key IndicationsSummaryGBI Research?s new report, ?Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhi...(more)

Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
Published by GBI Research in May 2012
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing ActivitySummaryGBI Research, the leading business intelligence provider, has released its latest research, ?Orphan Disea...(more)

Game Changers in Breast Cancer Therapies
Published by TriMark Publications in May 2012
Breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations. New market entrants must possess drug profiles and a savvy clinical development program to overcome such barriers to entry as a stringent regu...(more)



Previous 5 6 7 8 9 10 11 12 13 14 Next



Home | About | Market Research by Sector |
Pharmaceutical Research Firms | Pharmaceutical Suppliers Directory | faq | Privacy | Terms
Site Contents

Office Address: Chiltern Magazine Services Ltd., P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK.

Telephone: UK +44 (0) 1494 771734 Fax: +44 (0) 01494 778994 e-mail: keithw@cmsinfo.com
Telephone: USA +(1) 508 861 0401 Fax: +(1) 508 861 0401

Registered Office: 2a Altons House Office Park, Gatehouse Way, Aylesbury, HP19 3XU, UK
Registered in England and Wales No. 3240740 VAT No. GB 685 4343 10

CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740).
CMSInfo is also registered in accordance with the Data Protection Act 1998 (registration number R0094104).

Terms and Conditions


Site maintenance by R V Williams